i figure a small parcel making up 1-2% of my portfolio its a good punt:
- its got a beaten down sp
- a positive catalyst due shortly in the ce mark
- genuinely innovative product in an area of need
- good preliminary data
- phase 2 studies starting shortly
- strong institutional affiliations in usa/ uk
worse case scenario, it doesnt get the ce mark yet and drops a few more cents
best case, its the next sirtex (long shot but not out of the question) or a takeover target for a bigger biotech/ pharma
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.20 |
Change
-0.030(2.44%) |
Mkt cap ! $17.06M | |||
| Open | High | Low | Value | Volume |
| $1.25 | $1.25 | $1.20 | $31.40K | 25.53K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 90 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.20 | 2000 | 1 |
View Market Depth
| Last trade - 11.47am 27/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |